4 ms·
That's the industry PR line, at least. https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-pharmaceutical-companies-are-spending-far-more-on-marketing-t
by ceejayoz 4y ago
That's the industry PR line, at least.
https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-pharmaceutical-companies-are-spending-far-more-on-marketing-than-research/ https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-p...
> The biggest spender, Johnson & Johnson, shelled out $17.5 billion on sales and marketing in 2013, compared with $8.2 billion for R&D. In the top 10, only Roche spent more on R&D than on sales and marketing.
- noirbot 4y agoThat doesn't seem to contravene what was being said? The assertion was that the US (via higher prices) is what pays for the R&D. Not they they exclusively spend all the US profits on R&D. If the companies suddenly made 20 billion less, I'd expect the proportionate expense on Sales vs. R&D to stay roughly the same?